Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

FDA calendars are stacking up fast, obesity Phase 3 data is closing in, and three biotech names spanning the risk spectrum ...

Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

Artificial intelligence (AI), now firmly embedded into the fabric of everyday life, is nevertheless not immune to the market ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...

Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?